Agenda Clinical Hematology & Oncology 2023

7 a.m.

Registration, Breakfast & View Exhibits

Non-CME Breakfast Symposium Hosted by AbbVie

Pivotal Phase 3 Data in Newly Diagnosed AML

Jamie Koprivnikar, MD

TOPIC: NON-MALIGNANT HEMATOLOGY

Moderator: Emily Nagler, MD

7:55 a.m.

Welcome & Announcements

Michael P. Kosty, MD

8 a.m.

ITP: What Has Changed and What Has Not

John Kelton, MD

8:30 a.m.

Bleeding and Clotting Side Effects of Drugs Used by the Oncologist

Allison Burnett, PharmD

9 a.m.

Approach to Bleeding of Unknown Cause

Ming Lim, MBBCH, MS

9:30 a.m.

Panel Discussion/Q&A

Allison Burnett, PharmD, John Kelton, MD and Ming Lim, MBBCH, MS

10 a.m.

Break & View Exhibits

10:30 a.m.

Robert L. Longmire Lectureship

Thrombosis and Anticoagulation: 2023 Update

Stephan Moll, MD

11 a.m.

Hereditary Hemorrhagic Telangiectasia: 2023 Update

Raj Kasthuri, MBBS

11:30 a.m.

Sickle Cell Disease: 2023 Update

Samuel Wilson, MD 

Noon

Panel Discussion/Q&A

Raj Kasthuri, MBBS, Stephan Moll, MD, and Samuel Wilson, MD 

12:30 p.m.

Lunch

Non-CME Lunch Symposium Hosted by Pfizer

A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation

Anne O’Dea, MD

TOPIC: HEMATOLOGY & MALIGNANT HEMATOLOGY

Moderator: David Hermel, MD

1:30 p.m.

Outpatient DVT Prophylaxis in Oncology Patients: Who Should Get It and How Are We Doing In Our Practices?

Karlyn Martin, MD

2 p.m.

Best Frontline Treatment of CLL

Susan O’Brien, MD

2:30 p.m.

DLBCL – Will Bispecific Antibodies Compete with CAR-T?

Jeremy Abramson, MD

3 p.m.

Panel Discussion/Q&A

Jeremy Abramson, MD, Karlyn Martin, MD, and Susan O’Brien, MD

3:30 p.m.

Break & View Exhibits

3:45 p.m.

Chemo and Non-Chemotherapy Options for Patients with Waldenstrom's Macroglobulinemia

Morie Gertz, MD

4:15 p.m.

Immunological Treatment Advances in Hodgkin Disease

Ranjana Advani, MD

4:45 p.m.

Chemotherapy-Free Treatment of Ph(+) ALL

Nicholas Short, MD

5:15 p.m.

Panel Discussion/Q&A

Ranjana Advani, MD, Morie Gertz, MD, and Nicholas Short, MD

5:45 p.m.

Adjourn

5:45 p.m.

Welcome Reception

6 p.m.

Non-CME Dinner Symposium Hosted by Exelixis

Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer

Munveer Bhangoo, MD

7 a.m.

Breakfast & View Exhibits

Non-CME Breakfast Symposium Hosted by Seagen

A Review of Evidence-Based Data for an Antibody-Drug Conjugate for la/MUC

Przemyslaw Twardowski, MD

TOPIC: ONCOLOGY

Moderator: Kathryn Bollin, MD

7:55 a.m.

Welcome & Announcements

Michael P. Kosty, MD

8 a.m.

Bernard L. Schwartz Lectureship

Update on Management of Patients with Myeloproliferative Disorders

Ayalew Tefferi, MD

8:30 a.m.

Chemo and Non-Chemotherapy Treatment of Mantle Cell Lymphoma

Michael Wang, MD

9 a.m.

Novel Strategies in the Management of Brain Metastasis

Isabella Glitza, MD

9:30 a.m.

Panel Discussion/Q&A

Isabella Glitza, MD, Ayalew Tefferi, MD, and Michael Wang, MD

10 a.m.

Break & View Exhibits

10:30 a.m.

Approaches to the Patient with Metastatic Urothelial Cancer

Jean Hoffman-Censits, MD

11 a.m.

The Role of Immunotherapy and Targeted Therapy in GYN Cancers 

Stephanie Gaillard, MD

11:30 a.m.

Clinical Role of ctDNA Assays in Decision-making for Colorectal Cancer Adjuvant Therapy

Stacey Cohen, MD

Noon

Panel Discussion/Q&A

Stacey Cohen, MD, Stephanie Gaillard, MD, and Jean Hoffman-Censits, MD

12:30 p.m.

Lunch

Non-CME Lunch Symposium Hosted by Genentech

Evolving CLL Treatment Paradigms Exploring Chemo Free Regimens With A Fixed Treatment Duration

Catherine Coombs, MD

Non-CME Lunch Symposium Hosted by Bristol Myers Squibb

Hematologist & Oncologist Perspectives on Properly Diagnosing, Classifying, and Managing Low-Risk Myelodysplastic Syndromes

David Hermel, MD & Marin Xavier, MD

TOPIC: ONCOLOGY

Moderator: Aditya Sarvaria, MD

1:30 p.m.

Approaches to Metastatic Castration Sensitive Prostate Cancer – Patient and Regimen Selection

Sandy Srinivas, MD

2 p.m.

When Patients Progress: Treating Progressive NSCLC

Vamsidhar Velcheti, MD

2:30 p.m.

Newer Immunotherapeutic Options for Metastatic Melanoma

April Salama, MD

3 p.m.

Panel Discussion/Q&A

April Salama, MD, Sandy Srinivas, MD, and Vamsidhar Velcheti, MD

3:30 p.m.

Break & View Exhibits

CONCURRENT BREAKOUT SESSIONS

4 p.m.

Breakout #1: Clinical Case Studies in Thrombosis

Raj Kasthuri, MBBS

Breakout #2: Clinical Case Studies of Clotting Disorders in High-Level Athletes and Other Patients Engaged in Sports

Stephan Moll, MD

Breakout #3: Clinical Case Studies in Hemoglobinopathies

Samuel Wilson, MD 

Breakout #4: Clinical Case Studies in Refractory Clotting Disorders

Karlyn Martin, MD

5 p.m.

Adjourn

5:30 p.m.

Non-CME Dinner Symposium Hosted by Beigene

Brukinsa (Zanubrutinib) for Adult Patients With CLL/SLL

Herbert Eradat, MD

7 a.m.

Breakfast & View Exhibits

Non-CME Breakfast Symposium Hosted by Genentech 

LUNSUMIO™ (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular Lymphoma

Enrique Diaz, MD

Non-CME Breakfast Symposium Hosted by Astellas Pharma & Pfizer

Elevate Care in Advanced Prostate Cancer

Przemyslaw Twardowski, MD

TOPIC: BREAST CANCER

Moderator: Farah Nasraty, MD

7:55 a.m.

Welcome & Announcements

Michael P. Kosty, MD

8 a.m.

Redefining Triple Negative Breast Cancer

Heather McArthur, MD

8:30 a.m.

Optimal Duration of Endocrine Therapy

Virginia Kaklamani, MD

9 a.m.

Treatment of the Axilla in Early Breast Cancer

Mehra Golshan, MD

9:30 a.m.

Panel Discussion/Q&A

Mehra Golshan, MD, Virginia Kaklamani, MD, and Heather McArthur, MD

10 a.m.

Break & View Exhibits

10:30 a.m.

How to Manage Patients with Small HER-2 (+) Tumors

Mothaffar Rimawi, MD

11 a.m.

Future of ADC Therapy of Breast Cancer

Hope Rugo, MD

11:30 a.m.

Practical Management of AI-related Side-Effects

Mohammed Jaloudi, MD

Noon

Panel Discussion/Q&A

Mohammed Jaloudi, MD, Mothaffar Rimawi, MD, and Hope Rugo, MD

12:30 p.m.

Final Adjournment

Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.